Examine This Report on ADH-503
The study exhibits pirfenidone as a possible multitarget agent versus scarring soon after glaucoma filtration surgical procedures by developing the antiangiogenesis influence of it within the wound healing course of actionphenobarbital will minimize the level or outcome of pirfenidone by affecting hepatic enzyme CYP1A2 metabolism. Contraindicated.